NDLI: Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis

Content Provider	PubMed Central
Author	Desmet, Christophe J. Tristan, Gallenne Prieur, Alexandre Fabien, Reyal Visser, Nils L. Wittner, Ben S. Smit, Marjon A. Geiger, Thomas R. Laoukili, Jamila Sedef, Iskit Boris, Rodenko Zwart, Wilbert Evers, Bastiaan Hugo, Horlings Ajouaou, Abderrahrim John, Zevenhoven Vliet, Martin Van Ramaswamy, Sridhar Wessels, Lodewyk F. A. Peeper, Daniel S.
Abstract	Metastasis confronts clinicians with two major challenges: estimating the patient's risk of metastasis and identifying therapeutic targets. Because they are key signal integrators connecting cellular processes to clinical outcome, we aimed to identify transcriptional nodes regulating cancer cell metastasis. Using rodent xenograft models that we previously developed, we identified the transcription factor Fos-related antigen-1 (Fra-1) as a key coordinator of metastasis. Because Fra-1 often is overexpressed in human metastatic breast cancers and has been shown to control their invasive potential in vitro, we aimed to assess the implication and prognostic significance of the Fra-1–dependent genetic program in breast cancer metastasis and to identify potential Fra-1–dependent therapeutic targets. In several in vivo assays in mice, we demonstrate that stable RNAi depletion of Fra-1 from human breast cancer cells strongly suppresses their ability to metastasize. These results support a clinically important role for Fra-1 and the genetic program it controls. We show that a Fra-1–dependent gene-expression signature accurately predicts recurrence of breast cancer. Furthermore, a synthetic lethal drug screen revealed that antagonists of the adenosine receptor A2B (ADORA2B) are preferentially toxic to breast tumor cells expressing Fra-1. Both RNAi silencing and pharmacologic blockade of ADORA2B inhibited filopodia formation and invasive activity of breast cancer cells and correspondingly reduced tumor outgrowth in the lungs. These data show that Fra-1 activity is causally involved in and is a prognostic indicator of breast cancer metastasis. They suggest that Fra-1 activity predicts responsiveness to inhibition of pharmacologically tractable targets, such as ADORA2B, which may be used for clinical interference of metastatic breast cancer.
Related Links	http://dx.doi.org/10.1073/pnas.1222085110
Ending Page	5144
Page Count	6
Starting Page	5139
File Format	PDF
ISSN	00278424
e-ISSN	10916490
Journal	Proceedings of the National Academy of Sciences of the United States of America
Issue Number	13
Volume Number	110
Language	English
Publisher	National Academy of Sciences
Publisher Date	2013-03-26
Access Restriction	Open
Rights Holder	National Academy of Sciences
Subject Keyword	General Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Multidisciplinary

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis.

SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis

Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival

Neuregulin 1-HER axis as a key mediator of hyperglycemic memory effects in breast cancer

Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease

Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis

Complexity of metastasis-associated SDF-1 ligand signaling in breast cancer stem cells

Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma

Saikosaponin A Inhibits Triple-Negative Breast Cancer Growth and Metastasis Through Downregulation of CXCR4

Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis

Similar Documents

Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis.

SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis

Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival

Neuregulin 1-HER axis as a key mediator of hyperglycemic memory effects in breast cancer

Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease

Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis

Complexity of metastasis-associated SDF-1 ligand signaling in breast cancer stem cells

Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma

Saikosaponin A Inhibits Triple-Negative Breast Cancer Growth and Metastasis Through Downregulation of CXCR4

Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis